|
| Press Releases |
|
 |
|
| Tuesday, December 1, 2020 |
|
|
BioVaxys Provides Viral Vaccine Platform Program Update |
| BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) ("BioVaxys" or "the Company") is pleased to announce that it has received further data from its successfully completed murine model study demonstrating that immunizing mice with two doses of BVX-0320, its COVID-19 vaccine candidate, induced high levels of antibodies against the S1 fragment of the SARS-CoV-2 spike protein associated with inhibition of the binding of the virus to cells of the respiratory tract. more info >> |
|
| Monday, November 30, 2020 |
|
|
BioVaxys Provides Viral Vaccine Platform Program Update |
| BioVaxys Technology Corp. (CSE: BIOV) is pleased to announce that it has received further data from its successfully completed murine model study demonstrating that immunizing mice with two doses of BVX-0320, its COVID-19 vaccine candidate, induced high levels of antibodies against the S1 fragment of the SARS-CoV-2 spike protein associated with inhibition of the binding of the virus to cells of the respiratory tract. more info >> |
|
| Wednesday, November 11, 2020 |
|
|
BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine |
| BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) ("BioVaxys") is pleased to announce that results from its preclinical animal study (also known as the "murine model study") of BVX-0320, its Covid-19 vaccine candidate, show that the vaccine elicits a positive immune response against the SARS-CoV-2 s-spike protein. more info >> |
|
| Monday, November 2, 2020 |
|
|
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity |
| BioVaxys Technology Corp. (CSE: BIOV) ("BioVaxys" or "the Company"), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related to the potential development of a diagnostic for evaluating the presence or absence of a T-cell immune response to SARS-CoV-2, the virus that causes COVID-19. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
UREEQA Welcomes Dean Drever, a Sculptor Who Has Produced Multi-Million Dollar Works of Art 
Mar 6, 2021 23:00 HKT/SGT
|
|
|
Tianyun International: Rainbow Lead Ventures Limited Becomes a New Strategic Shareholder of the Group
Mar 6, 2021 14:10 HKT/SGT
|
|
|
Eisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer's Disease and Dementia at the 15th International Conference on Alzheimer's and Parkinson's Disease
Mar 5, 2021 16:51 HKT/SGT
|
|
|
CUPNOODLES MUSEUM HONG KONG BY NISSIN FOODS SET FOR LAUNCH
Mar 5, 2021 12:53 HKT/SGT
|
|
|
Moonstake Partners with P2P Escrow Service Escaroo
Mar 5, 2021 12:30 HKT/SGT
|
|
|
MHI Group Presents "Best Innovation 2020" Awards for Activities that Contribute to Reducing Environmental Loads
Mar 5, 2021 08:30 HKT/SGT
|
|
|
CoinSmart Closes CAD$4.5 Million Seed Funding; Plans to Expand into Europe
Mar 5, 2021 08:17 HKT/SGT
|
|
|
China Gas Enters into Strategic Cooperation Framework Agreement with Sinopec
Mar 4, 2021 21:22 HKT/SGT
|
|
|
Acquiring Xiaoer Qingre Zhike granule, Tianda Pharmaceuticals continues to broaden its product mix and perfect its Chinese medicine whole industry chain layout
Mar 4, 2021 19:43 HKT/SGT
|
|
|
Billboard Hot 100 #1 Hit of the Year Band Member Partners with UREEQA
Mar 4, 2021 18:50 HKT/SGT
|
|
|
CITIC Telecom Announces 2020 Annual Results
Mar 4, 2021 18:45 HKT/SGT
|
|
|
Showa Denko Announces Notice of Execution of Basic Agreement regarding Tender Offer over Subsidiary
Mar 4, 2021 17:00 HKT/SGT
|
|
|
Honda to Begin Sales of Legend with New Honda SENSING Elite
Mar 4, 2021 15:29 HKT/SGT
|
|
|
Former Head of Operations of Binance Global Fiat Exchanges becomes COO of BitWell
Mar 4, 2021 13:00 HKT/SGT
|
|
|
A & S Group assisted in vaccines air freight forwarding ground handling services to support anti-virus measures actively
Mar 4, 2021 11:45 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
